CBTE is my #1 stock pick. CBTE has less than 4 mil O/S. They are a contract research organization providig research and developement service to the pharmacuetical, biotech, and government along with many other industries. A few of the services provided are DNA Analysis, Paternity testing, genomics, peptides, and food microbiology to name a few. The company is currently in the process of buying Mimotopes in an all stock deal for around 2 mil shares. The Co. they are buying is an Australian Company that have an international presence in the peptides. This acquistion will be voted on in February. Along with the synergies involved they also bring in some relationships in terms very large biotech firms such as Invitrogen Corp, Genzyme Pharmaceuticals, and Amgen. The expectation is these relationships to continue to develop and for new ones to be established going forward. While CBTE is currently losing money this merger will give CBTE a very seasoned sales and marketing team which is positioned in major global biotechnoly markets which CBTE so desperately lacks. Furthermore, the CEO is stepping down and will give the reins to DR. D'Sylva who is a very aggressive 38 year old Australian who will definately take this company to the next level.
